{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/incorporating-patient-voice-improve-ulcerative-colitis-recruitment#webpage",
"url": "https://www.fortrea.com/insights/incorporating-patient-voice-improve-ulcerative-colitis-recruitment",
"name": "Incorporating the patient voice to improve ulcerative colitis recruitment",
"description": "This Fortrea case study explores how incorporating the patient voice helped improve recruitment and engagement in ulcerative colitis clinical trials through more patient-centric study design and operational planning. Recruiting patients for inflammatory bowel disease studies can be challenging due to disease burden, treatment history, lifestyle impact, and patient concerns related to participation requirements. The case study highlights how patient voice insights were used to better understand participant expectations, barriers to enrollment, and factors influencing retention and engagement throughout the clinical trial process. By integrating patient-centric clinical trial design principles, tailored communication strategies, and insights from individuals living with ulcerative colitis, the approach supported improved patient recruitment clinical trials, stronger engagement, and more accessible study participation. This Fortrea case study demonstrates how patient-informed operational strategies can strengthen recruitment performance, improve the participant experience, and support more effective ulcerative colitis clinical trial execution."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Incorporating the patient voice to improve ulcerative colitis recruitment",
"item": "https://www.fortrea.com/insights/incorporating-patient-voice-improve-ulcerative-colitis-recruitment"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/incorporating-patient-voice-improve-ulcerative-colitis-recruitment#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/incorporating-patient-voice-improve-ulcerative-colitis-recruitment#webpage"
},
"headline": "Improving Ulcerative Colitis Recruitment Through Patient Voice Insights | Fortrea Case Study",
"description": "This Fortrea case study explores how incorporating the patient voice helped improve recruitment and engagement in ulcerative colitis clinical trials through more patient-centric study design and operational planning. Recruiting patients for inflammatory bowel disease studies can be challenging due to disease burden, treatment history, lifestyle impact, and patient concerns related to participation requirements. The case study highlights how patient voice insights were used to better understand participant expectations, barriers to enrollment, and factors influencing retention and engagement throughout the clinical trial process. By integrating patient-centric clinical trial design principles, tailored communication strategies, and insights from individuals living with ulcerative colitis, the approach supported improved patient recruitment clinical trials, stronger engagement, and more accessible study participation. This Fortrea case study demonstrates how patient-informed operational strategies can strengthen recruitment performance, improve the participant experience, and support more effective ulcerative colitis clinical trial execution.",
"genre": "Case Study",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-03-17",
"dateModified": "2025-03-17",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-03/mcs-may-improve-the-patient-experienc-in-oncology-studies.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/incorporating-patient-voice-improve-ulcerative-colitis-recruitment#webpage",
"url": "https://www.fortrea.com/insights/incorporating-patient-voice-improve-ulcerative-colitis-recruitment",
"name": "Incorporating the patient voice to improve ulcerative colitis recruitment",
"description": "This Fortrea case study explores how incorporating the patient voice helped improve recruitment and engagement in ulcerative colitis clinical trials through more patient-centric study design and operational planning. Recruiting patients for inflammatory bowel disease studies can be challenging due to disease burden, treatment history, lifestyle impact, and patient concerns related to participation requirements. The case study highlights how patient voice insights were used to better understand participant expectations, barriers to enrollment, and factors influencing retention and engagement throughout the clinical trial process. By integrating patient-centric clinical trial design principles, tailored communication strategies, and insights from individuals living with ulcerative colitis, the approach supported improved patient recruitment clinical trials, stronger engagement, and more accessible study participation. This Fortrea case study demonstrates how patient-informed operational strategies can strengthen recruitment performance, improve the participant experience, and support more effective ulcerative colitis clinical trial execution."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Incorporating the patient voice to improve ulcerative colitis recruitment",
"item": "https://www.fortrea.com/insights/incorporating-patient-voice-improve-ulcerative-colitis-recruitment"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/incorporating-patient-voice-improve-ulcerative-colitis-recruitment#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/incorporating-patient-voice-improve-ulcerative-colitis-recruitment#webpage"
},
"headline": "Improving Ulcerative Colitis Recruitment Through Patient Voice Insights | Fortrea Case Study",
"description": "This Fortrea case study explores how incorporating the patient voice helped improve recruitment and engagement in ulcerative colitis clinical trials through more patient-centric study design and operational planning. Recruiting patients for inflammatory bowel disease studies can be challenging due to disease burden, treatment history, lifestyle impact, and patient concerns related to participation requirements. The case study highlights how patient voice insights were used to better understand participant expectations, barriers to enrollment, and factors influencing retention and engagement throughout the clinical trial process. By integrating patient-centric clinical trial design principles, tailored communication strategies, and insights from individuals living with ulcerative colitis, the approach supported improved patient recruitment clinical trials, stronger engagement, and more accessible study participation. This Fortrea case study demonstrates how patient-informed operational strategies can strengthen recruitment performance, improve the participant experience, and support more effective ulcerative colitis clinical trial execution.",
"genre": "Case Study",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-03-17",
"dateModified": "2025-03-17",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-03/mcs-may-improve-the-patient-experienc-in-oncology-studies.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
Case Study